Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Th is a stupid buy now

<< Previous

Bullboard Posts

Next >>

Post by Trogarzonon Dec 13, 2022 9:50am

125 Views

Post# 35168162

Th is a stupid buy now

Looking at pharma like Pfizer puking cash lately and Th market scrap of lass than 100M with 80M sales for the next few years, 60M dept, 1 P3 Nash and a Paused P1 Cancer Platform... all of this priced in CDN 73 cents usd. You have to be retarded to not have a look at buying Th. Instead of putting 50 to 100M upfront eventually for Nash P3 coumpoud that is SAFE.. buy the friggen thing for 250M... F..ck his is agravating.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China